NIH form to snitch on plagiarizing intramural scientists.
Published Date: 9/16/2026
Notice
Summary
The NIH Intramural Research Program (IRP) relies on a trustworthy research record to sustain public confidence and advance public health. NIH maintains procedures in compliance with NIH policy and 42 CFR part 93 to evaluate allegations of research misconduct, including falsification, fabrication, and plagiarism, through a fair, consistent, and peer-informed process. The proposed web-based reporting form will help the Agency Intramural Research Integrity Officer (AIRIO) receive sufficient information needed to assess concerns and determine appropriate next steps. Reports may be submitted anonymously, with optional contact information for follow-up. Concerns may also be reported in person, by telephone, or by email.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Web Form for Reporting Misconduct
NIH is proposing a secure web form (IRRM) to report allegations of research misconduct to the Agency Intramural Research Integrity Officer (AIRIO). You can submit reports anonymously (the form does not require your name), or provide optional contact details for follow-up; reports may also be made in person, by telephone, or by email.
Estimated Time Burden for Respondents
NIH states there are no costs to respondents other than their time and estimates 16 NIH IRP respondents will each spend 15 minutes per response, for a total annualized burden of 4 hours. OMB approval for the collection is requested for 3 years.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-18877, Prospective Grant of an Exclusive Patent License: Development and Commercialization of Engineered Cell Therapies for the Treatment of HPV 16 E6-Expressing Cancers
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patents and patent applications listed in the Supplementary Information section of this notice to MedGene Therapeutics, Inc. ("MedGene"), a company located in Silver Spring, Maryland, the United States of America.
2026-18646, Draft NIH Biosafety Policy for Research Involving Biohazards
The NIH is updating its biosafety rules to keep research safe as science changes and grows. This new policy will replace old guidelines and affect anyone working with biohazards in NIH-funded research. They want your thoughts by October 19, 2026, to help shape these important safety updates without adding extra costs.
2026-18191, Submission for OMB Review; 30-Day Comment Request Data and Specimen Hub (DASH) (Eunice Kennedy Shriver National Institute of Child Health and Human Development)
The National Institutes of Health (NIH) is asking for public feedback on their Data and Specimen Hub (DASH), which helps researchers share important health data. This is a quick 30-day review to make sure the information collection is clear and useful. If you’re involved in health research or data sharing, your input by October 8, 2026, can help shape how DASH works without costing extra money or time.
2026-17899, Proposed Collection; 60-Day Comment Request; Assurance (Interinstitutional, Foreign, and Domestic) and Annual Report (Office of the Director)
The NIH wants your thoughts on their plan to keep track of animal research safety through yearly reports and assurances from institutions, both in the U.S. and abroad. This helps make sure labs follow the rules and protect animals, with no new costs or big changes expected. You’ve got until October 2, 2026, to share your feedback and help improve the process!
2026-17687, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in October 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, ensuring fair and confidential decisions. Scientists applying for grants in genetics, molecular sciences, oral health, and cancer research are the ones affected, with no direct cost changes announced.
2026-17438, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings in late September 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers applying for funding. No direct money changes are announced, but these reviews decide who gets research grants.
Previous / Next Documents
Previous: 2026-18936, Notice of Proposed Information Collection Request
The National Mediation Board (NMB) invites comments on the proposed information collection request as required by the Paperwork Reduction Act of 1995. The NMB is seeking the reinstatement, with non- substantive change, of a previously approved collection of information, entitled "Application for Investigation of Representation Dispute." The change to the information collection is a non-substantive one related to the change in the agency's Washington, DC headquarters address, which was effective August 1, 2026. This notice allows for 60 days for public comments.
Next: 2026-18938, Product Change-Priority Mail, and USPS Ground Advantage Negotiated Service Agreements
The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.